Company: ARVN
Filing Date: 2025-08-06
Form Type: 10-Q
Source: 0001655759-25-000139
Chunk: 183

Company: ARVINAS, INC.
Filing Date: 2025-08-06
Form: 10-Q
Item: Part I, Item 8
Chunk 183
---
vinas Operations, Inc., Arvinas Androgen Receptor, Inc., Arvinas Estrogen Receptor, Inc., and Arvinas Winchester, Inc.

Critical Accounting Estimates 

Our management’s discussion and analysis of financial condition and results of operations is based on our unaudited condensed consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of our unaudited condensed consolidated financial statements and related disclosures requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, costs and expenses and the disclosure of contingent assets and liabilities in our unaudited condensed consolidated financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions. 

There have been no material changes to our critical accounting estimates from those described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission on February 11, 2025.

34

Results of Operations

Comparison of the Three and Six Months Ended June 30, 2025 and 2024

For the Three Months EndedJune 30,For the Six Months EndedJune 30,(dollars in millions)20252024$ change20252024$ changeRevenue$22.4 $76.5 $(54.1)$211.2 $101.8 $109.4 Research and development expenses(68.6)(93.7)25.1 (159.4)(178.0)18.6 General and administrative expenses(25.3)(31.3)6.0 (51.9)(55.6)3.7 Other income10.0 13.5 (3.5)21.6 27.5 (5.9)Income tax benefit (expense)0.3 (0.2)0.5 0.2 (0.3)0.5 Net (loss) income$(61.2)$(35.2)$(26.0)$21.7 $(104.6